Tag: LLS

LLS and Partners Commit $4.5 Million For Blood Cancer Patients Impacted By COVID-19

Stuart Mitchell

In the wake of the COVID-19 pandemic, The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer, along with valued partners, announced their commitment to help as many blood cancer patients as possible during this unprecedented crisis. The LLS COVID-19 Patient Financial Aid Program will begin immediately to provide $250 to eligible patients struggling with the economic hardship presented by the pandemic. Joining LLS in this critical initiative, one of the first to meet the urgent needs of blood cancer patients during this crisis, are leading…

Read More

A $50 Million Initiative to Fuel the Next Generation of Cancer Research for Generations to Come

Stuart Mitchell

Blood Cancer Awareness Month in September provides an opportunity to remind the public about the urgent need to support research to find cures, and The Leukemia & Lymphoma Society (LLS) is marking the occasion with a reinvigorated focus on helping children with cancer live better, longer lives. LLS announced today it has more than doubled its funding of research focused specifically on childhood blood cancers, adding 20 new research grants valued at more than $13.8 million to its research portfolio in 2019.  With these new grants, LLS now has committed…

Read More

The Leukemia & Lymphoma Society celebrates 70-year legacy by launching new LLS Children’s Initiative, to accelerate new and better treatments for pediatric blood cancers

Stuart Mitchell

As an organization founded by a family for families, The Leukemia & Lymphoma Society (LLS) is celebrating 70 years of impact on generations of families, researchers and volunteers while looking to the future by redoubling its commitment to improve treatments and care for children with cancer. To accomplish its bold vision for children, LLS is launching The LLS Children’s Initiative to deliver cures and care for children by disrupting drug development for pediatric cancers and expanding the education and support the organization provides to children and their families. Founded in…

Read More

PatientPoint and The Leukemia & Lymphoma Society Launch National Education Campaign

Stuart Mitchell

Patient engagement leader PatientPoint® and The Leukemia & Lymphoma Society (LLS) today announced a partnership to bring empowering blood cancer education and coping tools to patients and caregivers in more than 600 oncology practices nationwide. Through their partnership, PatientPoint and LLS will deliver interactive blood cancer education and information about free LLS resources via exam-room touchscreens and digital screens in the physician back office. Every three minutes, someone in the U.S. is diagnosed with a form of blood cancer. More than 174,000 Americans received a blood cancer diagnosis in 2018. As…

Read More

The Leukemia & Lymphoma Society (LLS) Fuels the Next Generation of Cancer Research Committing More Than $188 Million in Funding

Stuart Mitchell

Driving the dizzying pace of breakthroughs in blood cancer treatments, The Leukemia & Lymphoma Society (LLS) announced today $42 million for 80 blood cancer research teams around the world. This latest infusion of funding by LLS, the world’s largest nonprofit devoted to curing blood cancers, brings the organization’s current commitment to more than $188 million in multi-year grants, supporting more than 240 top scientific investigators at the world’s most prestigious cancer institutions, including Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, Dana-Farber Cancer Institute, City of Hope and Stanford…

Read More